Tag: Lilly
Lilly scores FDA emergency authorization for Olumiant in COVID-19, its 2nd...
While the list of authorized medicines to treat COVID-19 remains quite short, with a new nod this week, Eli Lilly stands alone in having two therapeutic offerings.
Lilly’s...
COVID antibody drugs from Lilly and Regeneron won’t do much to...
When Eli Lilly won emergency use authorization for its COVID-19 antibody drug, bamlanivimab, earlier this week, beating Regeneron to the finish line in a...
Eli Lilly, Pfizer, Merck among Big Pharma losers in China’s latest...
Several pharma giants—including Merck, Novartis, Eli Lilly and Pfizer—have just lost procurement deals in China under the country's new bidding system.
The drugmakers lost out to domestic producers, which in some...
Eli Lilly launches low blood sugar awareness campaign with American Idol...
Eli Lilly is reenlisting its long-time ambassador, singer and songwriter Crystal Bowersox, to help people living with diabetes recognize and manage low blood sugar symptoms.
In...
Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is...
Boehringer Ingelheim and Eli Lilly’s Tradjenta is working to pick up share in an ultracompetitive diabetes market, and it’s hoping some new outcomes data...
